Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the united states. JAMA. 2007, 298: 2038-2047. 10.1001/jama.298.17.2038.
Article
CAS
PubMed
Google Scholar
Hsu CY, McCulloch CE, Fan D, Ordonez JD, Chertow GM, Go AS: Community-based incidence of acute renal failure. Kidney Int. 2007, 72: 208-212. 10.1038/sj.ki.5002297.
Article
PubMed
PubMed Central
Google Scholar
Muntner P, He J, Hamm L, Loria C, Whelton PK: Renal insufficiency and subsequent death resulting from cardiovascular disease in the united states. J Am Soc Nephrol. 2002, 13: 745-753.
PubMed
Google Scholar
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351: 1296-1305. 10.1056/NEJMoa041031.
Article
CAS
PubMed
Google Scholar
Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, Newman AB, Sarnak MJ: Rapid kidney function decline and mortality risk in older adults. Arch Intern Med. 2008, 168: 2212-2218. 10.1001/archinte.168.20.2212.
Article
PubMed
PubMed Central
Google Scholar
van Domburg RT, Hoeks SE, Welten GM, Chonchol M, Elhendy A, Poldermans D: Renal insufficiency and mortality in patients with known or suspected coronary artery disease. J Am Soc Nephrol. 2008, 19: 158-163. 10.1681/ASN.2006101112.
Article
PubMed
PubMed Central
Google Scholar
Stocker R, Glazer AN, Ames BN: Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA. 1987, 84: 5918-5922. 10.1073/pnas.84.16.5918.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lanone S, Bloc S, Foresti R, Almolki A, Taille C, Callebert J, Conti M, Goven D, Aubier M, Dureuil B, El-Benna J, Motterlini R, Boczkowski J: Bilirubin decreases nos2 expression via inhibition of nad(p)h oxidase: Implications for protection against endotoxic shock in rats. FASEB J. 2005, 19: 1890-1892.
CAS
PubMed
Google Scholar
Sano K, Nakamura H, Matsuo T: Mode of inhibitory action of bilirubin on protein kinase c. Pediatr Res. 1985, 19: 587-590.
Article
CAS
PubMed
Google Scholar
Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M, Hasegawa G, Nakamura N: Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int. 2008, 74: 1197-1201. 10.1038/ki.2008.398.
Article
CAS
PubMed
Google Scholar
Targher G, Zoppini G, Cesare Guidi G, Lippi G: Relationship between serum bilirubin and kidney function in non-diabetic and diabetic individuals. Kidney Int. 2009, 75: 863-
Article
CAS
PubMed
Google Scholar
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003, 26: S5-20.
Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med. 2006, 354: 2473-2483. 10.1056/NEJMra054415.
Article
CAS
PubMed
Google Scholar
Kumar A, Pant P, Basu S, Rao GR, Khanna HD: Oxidative stress in neonatal hyperbilirubinemia. J Trop Pediatr. 2007, 53: 69-71.
Article
PubMed
Google Scholar
Schwertner HA, Jackson WG, Tolan G: Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 1994, 40: 18-23.
CAS
PubMed
Google Scholar
Breimer LH, Wannamethee G, Ebrahim S, Shaper AG: Serum bilirubin and risk of ischemic heart disease in middle-aged british men. Clin Chem. 1995, 41: 1504-1508.
CAS
PubMed
Google Scholar
Djousse L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC: Total serum bilirubin and risk of cardiovascular disease in the framingham offspring study. Am J Cardiol. 2001, 87: 1196-1200. 10.1016/S0002-9149(01)01494-1.
Article
CAS
PubMed
Google Scholar
Nakagami T, Toyomura K, Kinoshita T, Morisawa S: A beneficial role of bile pigments as an endogenous tissue protector: Anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta. 1993, 1158: 189-193.
Article
CAS
PubMed
Google Scholar
Mietus-Snyder M, Friera A, Glass CK, Pitas RE: Regulation of scavenger receptor expression in smooth muscle cells by protein kinase c: A role for oxidative stress. Arterioscler Thromb Vasc Biol. 1997, 17: 969-978. 10.1161/01.ATV.17.5.969.
Article
CAS
PubMed
Google Scholar
Koya D, King GL: Protein kinase c activation and the development of diabetic complications. Diabetes. 1998, 47: 859-866. 10.2337/diabetes.47.6.859.
Article
CAS
PubMed
Google Scholar
Roh DD, Kamanna VS, Kirschenbaum MA: Oxidative modification of low-density lipoprotein enhances mesangial cell protein synthesis and gene expression of extracellular matrix proteins. Am J Nephrol. 1998, 18: 344-350. 10.1159/000013363.
Article
CAS
PubMed
Google Scholar
Suzuki D, Miyata T, Saotome N, Horie K, Inagi R, Yasuda Y, Uchida K, Izuhara Y, Yagame M, Sakai H, Kurokawa K: Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol. 1999, 10: 822-832.
CAS
PubMed
Google Scholar
Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with risk of death. Diabetes. 2002, 51: 1157-1165. 10.2337/diabetes.51.4.1157.
Article
CAS
PubMed
Google Scholar
de Alwis NM, Day CP: Non-alcoholic fatty liver disease: The mist gradually clears. J Hepatol. 2008, 48: S104-112.
Article
PubMed
Google Scholar
Chang Y, Ryu S, Sung E, Woo HY, Oh E, Cha K, Jung E, Kim WS: Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism. 2008, 57: 569-576. 10.1016/j.metabol.2007.11.022.
Article
CAS
PubMed
Google Scholar
Targher G, Chonchol M, Bertolini L, Rodella S, Zenari L, Lippi G, Franchini M, Zoppini G, Muggeo M: Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol. 2008, 19: 1564-1570. 10.1681/ASN.2007101155.
Article
CAS
PubMed
PubMed Central
Google Scholar